Verition Fund Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.44M Buy
+23,800
New +$2.69M 0.02% 919
2025
Q4
Sell
-37,200
Closed -$4.98M 3462
2025
Q3
$4.98M Sell
37,200
-6,900
-16% -$906K 0.02% 1163
2025
Q2
$6M Buy
44,100
+12,400
+39% +$1.64M 0.03% 943
2025
Q1
$4.21M Sell
31,700
-9,500
-23% -$1.21M 0.02% 980
2024
Q4
$4.66M Sell
41,200
-6,600
-14% -$763K 0.02% 934
2024
Q3
$5.45M Sell
47,800
-9,300
-16% -$1.02M 0.03% 799
2024
Q2
$5.93M Buy
57,100
+25,100
+78% +$2.66M 0.03% 623
2024
Q1
$3.64M Buy
32,000
+28,600
+841% +$3.28M 0.02% 869
2023
Q4
$374K Buy
3,400
+300
+10% +$30K ﹤0.01% 1660
2023
Q3
$300K Buy
+3,100
New +$326K ﹤0.01% 1731
2022
Q2
Sell
-9,000
Closed -$1.06M 2278
2022
Q1
$1.06M Buy
+9,000
New +$1.12M 0.01% 1415

Other funds holding ABT

Verition Fund Management's ABT Position: Q1 2026 in Review

Verition Fund Management reduced its Abbott (ABT) stake by 55% in Q1 2026, selling an estimated $1.5M and leaving 10,914 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1261.

Verition Fund Management first reported a position in ABT in Q2 2013 and has held it in 41 quarters since. The position peaked at $19.5M in Q2 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Verition Fund Management held 10,914 shares of Abbott worth $1.12M as of Q1 2026.
  • Verition Fund Management sold 13,242 Abbott shares in Q1 2026, an estimated $1.5M.
  • Abbott made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1261 holding.
  • Verition Fund Management first reported a position in Abbott in Q2 2013 and has held it in 41 quarters since.
  • Verition Fund Management's Abbott position peaked at $19.5M in Q2 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.